InvestorsHub Logo
Followers 22
Posts 3693
Boards Moderated 0
Alias Born 07/20/2006

Re: None

Saturday, 11/27/2021 4:18:09 PM

Saturday, November 27, 2021 4:18:09 PM

Post# of 183
Needham Thinks Collegium Pharmaceutical’s Stock is Going to Recover
November 26 2021 - 11:15AM

In a report released today, Serge Belanger from Needham maintained a Buy rating on Collegium Pharmaceutical (COLL – Research Report), with a price target of $28.00. The company's shares closed last Friday at $17.83, close to its 52-week low of $17.67. According to TipRanks.com, Belanger is a 3-star analyst with an average return of 1.8% and a 38.5% success rate. Belanger covers the Healthcare sector, focusing on stocks such as Clarus Therapeutics Holdings, Amphastar Pharmaceuticals, and KalVista Pharmaceuticals. Currently, the analyst consensus on Collegium Pharmaceutical is a Strong Buy with an average price target of $27.00.

https://ih.advfn.com/stock-market/NASDAQ/collegium-pharmaceutical-COLL/stock-news/86665851/needham-thinks-collegium-pharmaceutical-s-stock-i
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent COLL News